FOLH1 and prostate carcinoma: In this study, we endeavored to compare the performance of PET/CT modality using the more novel radiotracer [68Ga]Ga-PSMA with [18F]Fluorocholine for the assessment of prostate cancer patients as both modalities are performed routinely in different centers.